Summary
Horizon Therapeutics operates as a biopharmaceutical company. The Company develops, acquires, and commercializes late-stage biopharmaceutical therapies for the treatment of pain and inflammation as well as specialty and orphan diseases.
Deals Overview
All rights reserved. Copyright © 2025 Datasite
Senior Management
Tim Walbert
Chairman, President and CEO
Paul W. Hoelscher
CFO
Andy Pasternak
Chief Strategy Officer
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy